Previous 10 | Next 10 |
2024-05-10 00:25:23 ET Haemonetics Corporation (HAE) Q4 2024 Earnings Conference Call May 09, 2024 08:00 AM ET Company Participants Olga Guyette - Senior Director of Investor Relations and Treasury Christopher Simon - President and Chief Executive Officer James D...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
2024-05-09 06:06:01 ET More on Haemonetics Haemonetics Corporation: Improved Performance, Another Bolt-On Deal Haemonetics Q4 2024 Earnings Preview Haemonetics to buy Attune Medical for $160M Seeking Alpha’s Quant Rating on Haemonetics Historic...
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website PR Newswire Financial release accessible online BOSTON , May 9, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial res...
2024-05-08 11:44:12 ET More on Haemonetics Haemonetics Corporation: Improved Performance, Another Bolt-On Deal Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript Haemonetics to buy Attune Medical for $160M Seeking Alpha’s Quant Rating on Ha...
2024-04-28 13:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 PR Newswire BOSTON , April 10, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024...
2024-04-04 17:01:48 ET More on Haemonetics Haemonetics Corporation: Improved Performance, Another Bolt-On Deal Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript Haemonetics to buy Attune Medical for $160M Haemonetics beats Q3 top and bottom line ...
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge PR Newswire BOSTON , April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions...
Haemonetics Corporation Completes Acquisition of Attune Medical PR Newswire BOSTON , April 1, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive bette...
News, Short Squeeze, Breakout and More Instantly...
Haemonetics Corporation Company Name:
HAE Stock Symbol:
NYSE Market:
Haemonetics Corporation Website:
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device PR Newswire BOSTON , June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions ...
2024-06-12 07:15:07 ET Needham analyst issues BUY recommendation for HAE on June 12, 2024 05:38AM ET. The previous analyst recommendation was Hold. HAE was trading at $83.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst ...
2024-06-12 07:00:12 ET Mike Matson from Needham issued a price target of $112.00 for HAE on 2024-06-12 05:20:00. The adjusted price target was set to $112.00. At the time of the announcement, HAE was trading at $83.41. HAE currently trades -14.88% versus its 52 week high...